Integrin α5β1: a promising target for right ventricular dysfunction in pulmonary arterial hypertension
Sarah‐Eve Lemay(SNC-Lavalin (Canada)), Sébastien Bonnet(Institut universitaire de cardiologie et de pneumologie de Québec), Yann Grobs(Institut universitaire de cardiologie et de pneumologie de Québec), Sandra Martineau(Canadian Heart Research Centre), Steeve Provencher(Institut universitaire de cardiologie et de pneumologie de Québec), Sandra Breuils‐Bonnet, Mélanie Sauvaget(Canadian Heart Research Centre), Olivier Boucherat, Manon Mougin(Canadian Heart Research Centre), Charlie Théberge(Canadian Heart Research Centre), R. Desbiens(Lung Institute), Andréanne Pelletier(Canadian Heart Research Centre), Mégan Gilbert, Alice Bourgeois, François Potus(Queen's University)
Cited by 1
Related Papers
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth
|Cancer Cell|2007|1.5k
Novel Mutations and Decreased Expression of the Epigenetic Regulator <i>TET2</i> in Pulmonary Arterial Hypertension
|Circulation|2020|120
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
|Genetics in Medicine|2023|73
Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension
|American Journal of Respiratory and Critical Care Medicine|2020|34
ATP citrate lyase drives vascular remodeling in systemic and pulmonary vascular diseases through metabolic and epigenetic changes
|Science Translational Medicine|2024|33